CST
PFE icon

Charles Schwab Trust’s Pfizer PFE Stock Holding History

Charles Schwab Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Buy
16,129
+6,419
+66% +$168K 0.02% 137
2026
Q1 		$273K Sell
9,710
-2,109
-18% -$56.1K 0.02% 143
2025
Q4 		$294K Sell
11,819
-1,581
-12% -$39.9K 0.02% 153
2025
Q3 		$341K Buy
13,400
+4,552
+51% +$112K 0.02% 146
2025
Q2 		$214K Hold
8,848
– – 0.02% 172
2025
Q1 		$224K Buy
+8,848
New +$232K 0.02% 163
2024
Q2 		– Sell
-8,582
Closed -$238K – 156
2024
Q1 		$238K Sell
8,582
-19,358
-69% -$537K 0.02% 142
2023
Q4 		$804K Sell
27,940
-15,926
-36% -$481K 0.08% 97
2023
Q3 		$1.46M Buy
43,866
+5,197
+13% +$184K 0.16% 70
2023
Q2 		$1.47M Buy
38,669
+3,691
+11% +$144K 0.18% 61
2023
Q1 		$1.43M Sell
34,978
-6,615
-16% -$286K 0.17% 64
2022
Q4 		$2.13M Buy
41,593
+9,439
+29% +$453K 0.28% 51
2022
Q3 		$1.41M Sell
32,154
-706
-2% -$34.3K 0.24% 60
2022
Q2 		$1.72M Buy
32,860
+672
+2% +$34.2K 0.36% 47
2022
Q1 		$1.67M Sell
32,188
-1,410
-4% -$73.2K 0.29% 54
2021
Q4 		$1.98M Buy
33,598
+35
+0.1% +$1.73K 0.32% 45
2021
Q3 		$1.44M Sell
33,563
-10,605
-24% -$470K 0.28% 67
2021
Q2 		$1.73M Buy
44,168
+5,710
+15% +$222K 0.34% 58
2021
Q1 		$1.4M Buy
38,458
+4,038
+12% +$143K 0.29% 67
2020
Q4 		$1.27M Buy
34,420
+12,265
+55% +$450K 0.3% 70
2020
Q3 		$771K Sell
22,155
-1,923
-8% -$67.4K 0.24% 77
2020
Q2 		$746K Buy
24,078
+1,561
+7% +$53K 0.25% 81
2020
Q1 		$697K Sell
22,517
-10,126
-31% -$345K 0.29% 76
2019
Q4 		$1.21M Buy
32,643
+18,529
+131% +$660K 0.47% 55
2019
Q3 		$474K Buy
+14,114
New +$513K 0.22% 85

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Charles Schwab Trust's PFE Position: Q2 2026 in Review

Charles Schwab Trust increased its Pfizer (PFE) stake by 66% in Q2 2026, buying an estimated $168K and bringing the position to 16,129 shares worth $388K. The position accounts for 0.02% of the portfolio, ranked #137.

Charles Schwab Trust first reported a position in PFE in Q3 2019 and has held it in 25 quarters since. The position peaked at $2.13M in Q4 2022. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Charles Schwab Trust held 16,129 shares of Pfizer worth $388K as of Q2 2026.
  • Charles Schwab Trust bought 6,419 Pfizer shares in Q2 2026, an estimated $168K.
  • Pfizer made up 0.02% of Charles Schwab Trust's portfolio in Q2 2026, its #137 holding.
  • Charles Schwab Trust first reported a position in Pfizer in Q3 2019 and has held it in 25 quarters since.
  • Charles Schwab Trust's Pfizer position peaked at $2.13M in Q4 2022.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Charles Schwab Trust's 13F filing for Q2 2026, filed 10 Jul 2026.